Medifast (MED) Change in Accured Expenses (2010 - 2026)

Medifast's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 75.84% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.4 million (up 22.77% YoY) and the FY2025 annual result came in at -$23.9 million, up 31.67% from the prior year.
• Change in Accured Expenses was -$1.4 million for Q1 2026 at Medifast, up from -$4.3 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at -$364000.0 in Q4 2023 and bottomed at -$21.9 million in Q1 2023.
• A 5-year average of -$7.9 million and a median of -$6.1 million in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 97.63% — and 2024, when it sank 2982.14%.
• Medifast's Change in Accured Expenses stood at -$15.3 million in 2022, then jumped by 97.63% to -$364000.0 in 2023, then sank by 2982.14% to -$11.2 million in 2024, then surged by 61.65% to -$4.3 million in 2025, then surged by 66.33% to -$1.4 million in 2026.
• Business Quant data shows MED's Change in Accured Expenses at -$1.4 million in Q1 2026, -$4.3 million in Q4 2025, and -$516000.0 in Q3 2025.